Authors' reply to comment on "Cost-effectiveness analysis of Herpes Zoster vaccination in 50-to 85-year-old immunocompetent Belgian cohorts: a comparison between no vaccination, the adjuvanted subunit vaccine, and live-attenuated vaccine"
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2022 |
Schlagwörter: | Economics / Pharmacology. Therapy / Human medicine |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26916194 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/10067/1914710151162165141 |